Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea

Area of Science:

• Oncology
• Pharmacology
• Toxicology

Background:

• Antineoplastic agent-induced diarrhea is a severe, potentially life-threatening side effect.
• The exact mechanism of this toxicity is complex and not fully understood.
• Identifying the molecular initiating event (MIE) is crucial for effective management.

Purpose of the Study:

• To determine the specific molecular initiating event (MIE) for antineoplastic agents causing diarrhea.
• To investigate the initial molecular interactions leading to this adverse drug reaction.
• To enhance the prediction and management strategies for chemotherapy-induced diarrhea.

Main Methods:

• Utilized the Food and Drug Administration Adverse Event Reporting System to identify diarrhea-inducing drugs.
• Employed the quantitative structure-activity relationship (QSAR) platform of Toxicity Predictor.
• Analyzed adjusted odds ratios to detect drug signals associated with diarrhea.

Main Results:

• Progesterone receptor antagonists were identified as potential molecular initiating events (MIEs).
• These findings suggest a specific molecular pathway involved in antineoplastic agent-induced diarrhea.
• The study provides a basis for targeted interventions.

Conclusions:

• The identification of progesterone receptor antagonists as MIEs offers new insights into chemotherapy-induced diarrhea.
• This research may lead to improved predictive models for this adverse event.
• Understanding the MIE can guide the development of better management strategies for patients undergoing cancer treatment.